An atypical long-acting injectable antipsychotic: implications for pharmacotherapy of schizophrenia

被引：5
|
作者：
Dursun, S [1 ]
机构：
[1] Univ Manchester, Neurosci & Psychiat Unit, Manchester M13 9PT, Lancs, England
来源：
JOURNAL OF PSYCHOPHARMACOLOGY | 2005年 / 19卷 / 05期
关键词：
D O I：
10.1177/0269881105057347
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：3 / 4
页数：2
相关论文
共 50 条
  • [21] Guidelines on long-acting injectable atypical antipsychotics for first-episode schizophrenia
    Azorin, J. -M.
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2013, 39 : S121 - S123
  • [22] Safety of the first long-acting atypical antipsychotic
    Llorca, PM
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S99 - S99
  • [23] EFFECTIVENESS OF A LONG-ACTING INJECTABLE ANTIPSYCHOTIC IN FIRST-EPISODE SCHIZOPHRENIA: THE EONKCS STUDY
    Chiliza, Bonginkosi
    Asmal, Laila
    Emsley, Robin
    SCHIZOPHRENIA BULLETIN, 2015, 41 : S305 - S306
  • [24] Factors associated with relapse in schizophrenia despite adherence to long-acting injectable antipsychotic therapy
    Alphs, Larry
    Nasrallah, Henry A.
    Bossie, Cynthia A.
    Fu, Dong-Jing
    Gopal, Srihari
    Hough, David
    Turkoz, Ibrahim
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2016, 31 (04) : 202 - 209
  • [25] Controversies Surrounding the Use of Long-Acting Injectable Antipsychotic Medications for the Treatment of Patients with Schizophrenia
    Kane, John M.
    McEvoy, Joseph P.
    Correll, Christoph U.
    Llorca, Pierre-Michel
    CNS DRUGS, 2021, 35 (11) : 1189 - 1205
  • [26] Effects of aripiprazole long-acting injectable antipsychotic on hospitalization in recent-onset schizophrenia
    Karlovic, Dalibor
    Silic, Ante
    Crnkovic, Danijel
    Peitl, Vjekoslav
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2021, 36 (02)
  • [27] Management of Schizophrenia with Long-Acting Injectable Antipsychotic Medications: An Assessment of the Educational Needs of Clinicians
    Citrome, Leslie
    Belcher, Emily
    Stacy, Sylvie
    Suett, Mark
    Mychaskiw, Marko
    Salinas, Gregory D.
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2022, 18 : 111 - 123
  • [28] Long-Acting Injectable Antipsychotic Medications in Patients With Comorbid Schizophrenia and Substance Use Disorders
    Green, Alan I.
    JOURNAL OF DUAL DIAGNOSIS, 2012, 8 (01) : 62 - 63
  • [29] Long-Acting Injectable Antipsychotic Use in Patients with Schizophrenia and Criminal Justice System Encounters
    Bhatta, Madhav P.
    Bista, Saroj
    El Khoury, Antoine C.
    Hutzell, Eric G.
    Tandon, Neeta
    Smith, Douglas
    JOURNAL OF HEALTH ECONOMICS AND OUTCOMES RESEARCH, 2021, 8 (01): : 63 - 70
  • [30] Controversies Surrounding the Use of Long-Acting Injectable Antipsychotic Medications for the Treatment of Patients with Schizophrenia
    John M. Kane
    Joseph P. McEvoy
    Christoph U. Correll
    Pierre-Michel Llorca
    CNS Drugs, 2021, 35 : 1189 - 1205
12345